Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts

Green Thumb Industries

Market Cap: CA$2.2b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Trulieve Cannabis

Market Cap: CA$1.5b

Operates as a cannabis retailer.

Cresco Labs

Market Cap: CA$624.9m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Canopy Growth

Market Cap: CA$581.9m

Engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia.

Verano Holdings

Market Cap: CA$515.8m

Operates as a vertically integrated multi-state cannabis operator in the United States.

Spectral Medical

Market Cap: CA$374.5m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

TerrAscend

Market Cap: CA$300.3m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

High Tide

Market Cap: CA$282.8m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Aurora Cannabis

Market Cap: CA$277.9m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Organigram Global

Market Cap: CA$236.5m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

Auxly Cannabis Group

Market Cap: CA$164.0m

Operates as a consumer packaged goods company in the cannabis products market in Canada.

Cardiol Therapeutics

Market Cap: CA$156.4m

A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

HLS Therapeutics

Market Cap: CA$140.7m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.

Medexus Pharmaceuticals

Market Cap: CA$92.4m

Operates as a pharmaceutical company in Canada and the United States.

Vext Science

Market Cap: CA$71.5m

Through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States.

Medicenna Therapeutics

Market Cap: CA$68.4m

A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.

Decibel Cannabis

Market Cap: CA$54.8m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

ZYUS Life Sciences

Market Cap: CA$50.4m

Manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union.

Sernova Biotherapeutics

Market Cap: CA$45.8m

Operates as a clinical-stage biotechnology company in Canada.

Covalon Technologies

Market Cap: CA$43.9m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally.

Microbix Biosystems

Market Cap: CA$31.9m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

Rubicon Organics

Market Cap: CA$29.3m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

Delivra Health Brands

Market Cap: CA$5.8m

Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.